ANDROMEDA UNIVERSAL LTD
- 86220Specialist medical practice activities
Opportunity 74/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (78/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2024-10-31 | 2023-10-31 |
|---|
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
Corporate timeline (19 events)Click to expand
- 2025-10-29📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2024-10-30📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2023-10-31📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2022-10-29📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2021-10-30📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2020-10-31📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2019-07-31📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2018-08-02📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2018-08-02📄change-person-director-company-with-change-dateofficers · CH01
- 2018-08-02📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2018-07-31📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2018-07-31📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2017-04-21📄resolutionresolution · RESOLUTIONS
- 2017-01-07📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2015-10-14📄annual-return-company-with-made-up-date-full-list-shareholdersannual-return · AR01
- 2015-10-12➖TEHSEEN, Yildiz resigneddirector
- 2015-10-05🏢Company incorporatedAs ANDROMEDA UNIVERSAL LTD
- 2015-10-05➕FAYYAZ, Faisal, Dr appointeddirector
- 2015-10-05➕TEHSEEN, Yildiz appointeddirector
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Sole director: Only one active director — all governance concentrated on one person.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanShareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mrs Yildiz Tehseen Individual · British · DOB 04/1989 · age 37 | 25–50% | — | 25-50% shares | 01/10/2016 |
Dr Faisal Fayyaz Individual · British · DOB 01/1978 · age 48 | 25–50% | — | 25-50% shares | 01/10/2016 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · BS postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| AMG PHARMA LIMITED→ 10014144 · est 2016 · no financials extracted | — | — | — | — | 10y | — | — |
| ANCHOR COMMUNITY SUPPORT LTD→ 13493927 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| ANCHOR DAY NURSERY LIMITED→ 11102568 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| ANDISTAN CONSULTING LTD→ 14145327 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| ANDREIA LTD→ 15383572 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| ANGELA COURT LIMITED→ 09979289 · est 2016 · no financials extracted | — | — | — | — | 10y | — | — |
| ANGLO SUPPORT AND HOUSING LTD→ 10996564 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| ANKRUMAH LOCUMS LTD→ 09363780 · est 2014 · no financials extracted | — | — | — | — | 11y | — | — |
| ANNE'S HOUSE LIMITED→ 12661836 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| AONE CHILDREN'S SERVICES LTD→ 14127543 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| AONE HEALTHCARE SERVICES LTD→ 15085104 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AP FIRST AID TRAINING LTD→ 10211764 · est 2016 · no financials extracted | — | — | — | — | 9y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 1 resigned)
Click a director name to see their full track record across all companies.